In recent years, anti‑abortion advocates have relentlessly promoted false claims about the safety of medication abortion. In particular, they have distorted routine follow-up care, seizing upon the fact that people frequently seek medical care during or after a medication abortion. Like the broader attacks on mifepristone, one of two drugs used in the most common medication abortion regimen, these narratives often rely on cherry-picked data, faulty methodologies that misclassify expected symptoms as complications, and exaggerated claims about emergency department care—tactics designed to undermine medication abortion access rather than reflect patients’ real experiences.

While most people safely and comfortably manage their medication abortions at home, seeking in-person care is also a common part of the process for many people. This fact sheet situates care‑seeking within medication abortion’s established record of safety and efficacy, providing data to help explain and contextualize care-seeking behaviors, counter misinformation, and support patient‑centered care. It also provides background for a series of new publications from Guttmacher’s Online Medication Abortion Survey, which collects data on the characteristics and experiences of people seeking medication abortion online.

What Is Care-Seeking in the Context of Medication Abortion?

• Seeking in-person follow-up care, if desired, is a common and normal part of the medication abortion process, most of which typically takes place outside of clinical settings. Whether patients receive the medications in-person or in the mail, they are typically taking the pills at home or in an environment of their choosing—a feature of medication abortion that many patients prefer for the privacy and flexibility it affords them. Like miscarriage management and many interventions for common conditions such as urinary tract infections and kidney stones, medication abortion is a process that is primarily managed by the patient, followed by optional remote or in-person care to address symptoms, rule-out complications and confirm resolution.
• Decades of research have established the safety and efficacy of medication abortion care. This includes both the use of the combined mifepristone‒misoprostol regimen and the use of misoprostol alone. Evidence also shows that telehealth provision of medication abortion—where patients receive abortion pills by mail after a remote consultation with a US-based clinician—is similarly safe and effective, with 29% of US abortions being obtained via telehealth by the end of 2025.
• Serious adverse events—such as those requiring a transfusion or hospitalization—are exceptionally rare in medication abortion care, typically well below 1% of cases. (While all medical interventions are unique, this safety profile is comparable to that of ibuprofen, and represents lower risks than those posed by penicillin and Viagra.) To rule out these rare complications, providers often advise everyone experiencing a specific set of symptoms (such as prolonged heavy bleeding) to consult a clinician, even though most of them will not, in fact, be experiencing a serious adverse event.
• In the small number of cases (3‒5%) in which medication abortion is unsuccessful and the patient remains pregnant, the abortion can be safely and effectively completed with additional rounds of misoprostol or a procedural abortion. (These additional follow-up interventions are the same ones typically used to treat a miscarriage or early pregnancy loss.)
  

Why Do People Seek Care During or After Medication Abortion?

• Since home pregnancy tests can show “false positive” results up to five weeks after a successful abortion, in-person visits are also a way that people can confirm they are no longer pregnant. While remote or in-person follow-up is not routinely required after medication abortion, it can be an important way for patients to get advice on how to address their symptoms and to monitor their hormone levels if there are concerns about incomplete abortion.
• Most people who have a medication abortion will experience symptoms such as bleeding and cramping, and seeking in-person care is one way that they can confirm that these symptoms are normal and expected. Other reasons that people sometimes seek care after medication abortion include consultations for contraception and to confirm that any continuing symptoms (such as intermittent bleeding or fever) are normal and not a cause for concern.
• Since the Dobbs decision overturning a constitutional right to abortion, many people who would have sought an in-person consultation before a medication abortion are now prevented from doing so, due to abortion restrictions or the threat of criminalization.
• Care-seeking behavior is also impacted by a US context in which many people are uninsured or underinsured and have no access to a regular health care provider. This means that many people are forced to visit emergency departments to address a broad range of non-emergent conditions and concerns. Since abortion care is highly stigmatized and banned in many states, patients may have genuine fears about their legal safety. In this context, emergency departments may often be the most accessible and anonymous way to get information and resolve concerns.

Why Do We Need Better Data on Care-Seeking Behavior?

• Mis- and disinformation about medication abortion has proliferated in recent decades, in part because medication abortion—and especially its online provision—has become critically important to abortion access across the United States. (In 2023, medication abortion accounted for 65% of clinician-provided abortions in the United States.)
• Attacks on mifepristone, in particular, frequently take the form of biased and ideologically driven research papers, riddled with serious methodological flaws, which have subsequently been discredited by researchers and retracted by peer-reviewed journals. Common errors include characterizing incomplete abortion and unrelated conditions as serious adverse events, presenting expected rates of complications as new information, and categorizing all ER visits, for any reason, as serious adverse events. These attacks also frequently categorize normal symptoms as serious adverse events that do not meet the FDA’s criteria for such events.
• Information about care-seeking is also complicated by abortion bans and peoples’ legitimate fears about criminalization for a broad range of pregnancy outcomes including miscarriage or stillbirth. Particularly in states with restrictive abortion laws, seeking follow-up care after an abortion can put individuals at risk of criminalization; health care providers are often the ones reporting abortion patients to police, despite the fact that no state laws currently require such reporting to law enforcement. These factors make data collection in traditional medical settings far more complex and potentially inadequate.

As misinformation about abortion care proliferates, understanding people’s actual experiences with medication abortion and care-seeking is more important than ever. The data generated by the Online Medication Abortion Study provide a nuanced and detailed picture of the medication abortion process from the perspective of the patient and explores the various reasons that patients might seek in-person care before, during or after that process. While the science is clear on the safety and efficacy of medication abortion, we hope this research will inform best practices, help identify potential gaps in support and counseling, and drive patient-centered innovations in care provision and health policy.